Germany Medical Technology & Prosthesis Company Ottobock Frankfurt IPO to Raise $948 Million at $4.9 Billion Valuation with Expected IPO Listing on 9th October 2025, Founded in 1919 by Otto Bock & 3rd Generation Hans-Georg Naeder is Chairman of Ottobock
30th September | Hong Kong
Germany medical technology & prosthesis company Ottobock Frankfurt IPO is raising $948 million at $4.9 billion valuation with expected IPO listing on 9th October 2025. Ottobock was founded in 1919 by Otto Bock, and 3rd generation Hans-Georg Naeder is the Chairman of Ottobock. Ottobock – Helping people maintain or regain their freedom of movement – this is Ottobock’s mission. Just as it has been for over 100 years. Our med-tech company continually sets new standards in the fields of prosthetics and orthotics. In 1997, we launched the C-Leg, the world’s first leg prosthesis to be controlled completely by microprocessors. Our C-Brace mechatronic orthosis, which helps people to stand and walk again when they are affected by paralysis due to neurological conditions such as multiple sclerosis and strokes, still features absolutely unique technology. And our portfolio also features wheelchairs and exoskeletons. The latter relieve strain for people who do physically demanding jobs and make workplaces in the industrial, logistics and trade sectors more ergonomic. Tech, digital, human – Ottobock creates an integrated approach by combining innovative products with customised treatment. The company has over 240 of its own patient care centres worldwide, ensuring close relationships with users and providing key momentum for the improvement of existing solutions and the development of new ones. As we move forward with the digitalisation of the fitting process, we are boosting efficiency and making our treatment more comfortable – for external orthopaedics companies and medical supply companies as well. We have maintained a stable growth track for many years, and our sales topped the one billion mark for the first time in 2019. Our over 8,000 employees worldwide contribute to achieving this. We coordinate our international activities from our headquarters in Duderstadt, Germany. Thanks to a global network of research, production and logistics sites as well as sales and service companies in over 50 countries, we combine a genuine international approach with a local presence.
“ Germany Medical Technology & Prosthesis Company Ottobock Frankfurt IPO to Raise $948 Million at $4.9 Billion Valuation with Expected IPO Listing on 9th October 2025, Founded in 1919 by Otto Bock & 3rd Generation Hans-Georg Naeder is Chairman of Ottobock “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
Germany Medical Technology & Prosthesis Company Ottobock Frankfurt IPO to Raise $948 Million at $4.9 Billion Valuation with Expected IPO Listing on 9th October 2025, Founded in 1919 by Otto Bock & 3rd Generation Hans-Georg Naeder is Chairman of Ottobock
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
